Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY(PATENCY)

A legfontosabb adatok

Ki végzi
Lifetech Scientific (Shenzhen) Co., Ltd.
Hol
Kína21 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
150 fő vett részt
Kezdés
2019. febr. 1.
Befejezés
2025. jún. 1.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Artery Stent Graft System
A regiszteradat frissítve
2025. június 18.

Ki vehet részt

Életkor
18 év – 85 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 27 feltétel megnézéseKevesebb

Ki vehet részt

  • Patients are 18 years and older, but less than 85 years old and not pregnant or lactating
  • Patients who can understand the purpose of the trial, voluntarily participate in and sign the informed consent, and are willing to complete the follow-up according to the requirements of the protocol
  • Patients diagnosed as thoracic aortic dissection involving the arch, and the left subclavian artery branching vessel needs to be revascularized
  • Aortic proximal landing zone ≥15mm;
  • Aortic proximal diameter in the range of 25-44mm
  • The left subclavian artery distal landing zone≥15mm
  • The left subclavian artery diameter in the range of 5-18mm;
  • Patients who have eligible imported arterial vessels

Ki nem vehet részt

  • Patients have received any major surgical or interventional therapy within 30 days (Operation Classification reaches III or above) or have received interventional therapy
  • Patients will receive any major selective operation or interventional therapy in 30days (Operation Classification reaches III or above) or will received interventional therapy
  • Patients already treated with an thoracic aortic stent graft and the stent graft can affect operation or intersection part existing between the graft covering area;
  • Patients who participated in clinical trials of other drugs or medical devices at the same time
  • Patients need intervention for other vascular diseases (such as coronary artery /renal artery) in the same surgery, or patients with heart disease and medicine treatment will be affected by the intervention;
  • Patients with a history of myocardial infraction or acute coronary syndromes in 3 months;
  • Patients with a history of cerebrovascular events or gastrointestinal bleeding in 3 months, antiplatelet agent and anticoagulant contraindication, or tendency of hemorrhage;
  • Patients with genetic connective tissue disease (e.g., Marfans syndrome) or aorta hereditary disease;
  • Patients with acute systemic infection
  • Patients with major organ failure or other serious diseases
  • Patients with a history of active bleeding, clotting disorder, or rejection of blood transfusions
  • Patients with a history of allergy to contrast media, stents and conveyor materials (including nickel and titanium, polyester, PTFE, and nylon polymer materials)
  • Patients with a life expectancy less than 12 months(such as terminal malignant tumor);
  • Patients with liver dysfunction: preoperative creatinine was 2.5 times higher than the normal upper limit; Alanine transaminase (ALT) or Aspartate transaminase (AST) were 5 times higher than the normal upper limit; serum total bilirubin (STB) was 2 times higher than the normal upper limit
  • Patients with severe stenosis, calcification in the landing area of the stent and easily lead to incomplete stent apposition
  • Patients with infectious aortic dissection
  • Pregnant or lactating women or women who plan to get pregnant
  • Patients who can not tolerate to Anaesthetic;
  • Patients who were not suitable for endovascular treatment, judged by the investigator

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

A prospective, multi-centre, objective performance criteria clinical trial to evaluate the safety and efficacy of Artery Stent Graft System manufactured by Lifetech Scientific (Shenzhen) Co., LTD. for the thoracic aortic dissection involving the aortic arch.

A vizsgálat csoportja

  • Intervention armA vizsgált kezelés

    Participants will be treated with Artery Stent Graft System Intervention: Device: Artery Stent Graft System

    Kezelés: Artery Stent Graft System

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY:A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
Publikációk
A regiszteradat frissítve
2025. június 18.